Last reviewed · How we verify
Spinal analgesia for labour pain
At a glance
| Generic name | Spinal analgesia for labour pain |
|---|---|
| Sponsor | Helsinki University Central Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Spinal Analgesia in Labour Pain (PHASE1)
- Maternal Expectations on Labor Analgesia and Risk of Postpartum Depression: An Observational Study
- Spinal Fentanyl or Epidural Analgesia in the Early First Phase of Induced Labor (PHASE4)
- Determination of the Minimum Local Analgesic Dose of Spinal Chloroprocaine in Labour (PHASE4)
- Sacral Spread of Sensory Block After Dural Puncture Epidural Technique Compared With Epidural for Labour Analgesia (NA)
- Study Comparing Dural Puncture Epidural With Epidural and Combined Spinal Epidural Anesthesia for Obstetric Analgesia. (PHASE3)
- Comparison of Intratechal Levobupivacaine and Adding With Sufetanil and Fentanyl in Ceserean Section (PHASE2)
- Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: